Haematological recovery in dyskeratosis congenita patients treated with danazol

doi:10.1111/bjh.12432

Article

Haematological recovery in dyskeratosis congenita patients treated with danazol

19 Jun 2013

Abstract excerpt

Dyskeratosis Congenita (DC) is a multi-system disorder of telomere biology in which bone marrow (BM) failure is the main cause of mortality (Savage & Bertuch, 2010; Mason & Bessler, 2011). The disease spectrum has expanded considerably since its initial description and DC can involve any system with varying severity (Dokal, 2011). To date, 10 genes (DCK1, TERC, TERT, NOP10, NHP2, TINF2, USB1, TCAB1, CTC1 and...

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.